chr17-44914081-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002055.5(GFAP):c.469G>A(p.Asp157Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0165 in 1,549,378 control chromosomes in the GnomAD database, including 282 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 16 hom., cov: 32)
Exomes 𝑓: 0.017 ( 266 hom. )
Consequence
GFAP
NM_002055.5 missense
NM_002055.5 missense
Scores
9
9
Clinical Significance
Conservation
PhyloP100: 3.80
Publications
20 publications found
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
GFAP Gene-Disease associations (from GenCC):
- Alexander diseaseInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- Alexander disease type IIInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0133288205).
BP6
Variant 17-44914081-C-T is Benign according to our data. Variant chr17-44914081-C-T is described in ClinVar as Benign. ClinVar VariationId is 66485.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0109 (1658/152104) while in subpopulation NFE AF = 0.0173 (1179/67984). AF 95% confidence interval is 0.0165. There are 16 homozygotes in GnomAd4. There are 789 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1658 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GFAP | NM_002055.5 | c.469G>A | p.Asp157Asn | missense_variant | Exon 2 of 9 | ENST00000588735.3 | NP_002046.1 | |
| GFAP | NM_001363846.2 | c.469G>A | p.Asp157Asn | missense_variant | Exon 2 of 10 | NP_001350775.1 | ||
| GFAP | NM_001242376.3 | c.469G>A | p.Asp157Asn | missense_variant | Exon 2 of 7 | NP_001229305.1 | ||
| GFAP | NM_001131019.3 | c.469G>A | p.Asp157Asn | missense_variant | Exon 2 of 8 | NP_001124491.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GFAP | ENST00000588735.3 | c.469G>A | p.Asp157Asn | missense_variant | Exon 2 of 9 | 1 | NM_002055.5 | ENSP00000466598.2 |
Frequencies
GnomAD3 genomes AF: 0.0109 AC: 1657AN: 151986Hom.: 16 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1657
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0109 AC: 1746AN: 159742 AF XY: 0.0103 show subpopulations
GnomAD2 exomes
AF:
AC:
1746
AN:
159742
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0171 AC: 23837AN: 1397274Hom.: 266 Cov.: 30 AF XY: 0.0166 AC XY: 11443AN XY: 689466 show subpopulations
GnomAD4 exome
AF:
AC:
23837
AN:
1397274
Hom.:
Cov.:
30
AF XY:
AC XY:
11443
AN XY:
689466
show subpopulations
African (AFR)
AF:
AC:
94
AN:
31708
American (AMR)
AF:
AC:
177
AN:
35850
Ashkenazi Jewish (ASJ)
AF:
AC:
228
AN:
25080
East Asian (EAS)
AF:
AC:
0
AN:
35976
South Asian (SAS)
AF:
AC:
80
AN:
79362
European-Finnish (FIN)
AF:
AC:
805
AN:
48760
Middle Eastern (MID)
AF:
AC:
25
AN:
5596
European-Non Finnish (NFE)
AF:
AC:
21686
AN:
1077092
Other (OTH)
AF:
AC:
742
AN:
57850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1033
2066
3099
4132
5165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0109 AC: 1658AN: 152104Hom.: 16 Cov.: 32 AF XY: 0.0106 AC XY: 789AN XY: 74392 show subpopulations
GnomAD4 genome
AF:
AC:
1658
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
789
AN XY:
74392
show subpopulations
African (AFR)
AF:
AC:
128
AN:
41476
American (AMR)
AF:
AC:
89
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
25
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
6
AN:
4814
European-Finnish (FIN)
AF:
AC:
193
AN:
10576
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1179
AN:
67984
Other (OTH)
AF:
AC:
22
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
85
170
254
339
424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
76
ALSPAC
AF:
AC:
69
ESP6500AA
AF:
AC:
27
ESP6500EA
AF:
AC:
121
ExAC
AF:
AC:
741
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
-
Epithelial Biology; Institute of Medical Biology, Singapore
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
GFAP: BP4, BS1, BS2 -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:2
Mar 25, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;D;.;.;.;.;D;.;.;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;L;.;.;L;L;.;.;.;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
.;.;N;.;N;.;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
.;.;D;.;D;.;.;.;.;.
Sift4G
Uncertain
.;.;D;.;D;.;D;D;.;.
Polyphen
0.0040
.;B;.;.;.;.;.;.;.;.
Vest4
0.26, 0.27, 0.28
MPC
0.78
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.